We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The U.S. Food and Drug Administration (FDA) notified India Globalization Capital (IGC) it has authorized the initiation Phase 1 human trial study for the Company’s investigational cannabinoid formulation for the treatment of patients suffering from ...